Suppr超能文献

万古霉素和头孢他啶的生物活性在端口管腔内持续至少2周:采用抗生素封管技术简化端口相关血流感染的治疗。

Vancomycin and ceftazidime bioactivities persist for at least 2 weeks in the lumen in ports: simplifying treatment of port-associated bloodstream infections by using the antibiotic lock technique.

作者信息

Haimi-Cohen Y, Husain N, Meenan J, Karayalcin G, Lehrer M, Rubin L G

机构信息

Divisions of Infectious Diseases, Department of Pediatrics, Long Island Jewish Medical Center of the North Shore-Long Island Jewish Medical Center Health System, Albert Einstein College of Medicine, New Hyde Park, New York 11040, USA.

出版信息

Antimicrob Agents Chemother. 2001 May;45(5):1565-7. doi: 10.1128/AAC.45.5.1565-1567.2001.

Abstract

The residual antibiotic concentration of vancomycin (2 mg/ml)- or ceftazidime (2 mg/ml)-heparin solutions instilled in ports in pediatric hematology-oncology patients 1 to 34 days earlier was measured. Antibiotic concentrations of > or = 100 microg of either antibiotic per ml persisted for at least 21 days. For treatment of lumenal port infections, antibiotic-heparin dwell times of > or = 2 weeks may be appropriate.

摘要

测量了1至34天前向儿科血液肿瘤患者的端口中注入的万古霉素(2毫克/毫升)或头孢他啶(2毫克/毫升)-肝素溶液的残留抗生素浓度。每毫升两种抗生素中任一种抗生素浓度≥100微克的情况持续了至少21天。对于管腔内端口感染的治疗,抗生素-肝素保留时间≥2周可能是合适的。

相似文献

2
Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports).
Antimicrob Agents Chemother. 1999 Aug;43(8):2074-6. doi: 10.1128/AAC.43.8.2074.
3
Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial.
J Antimicrob Chemother. 2005 Jan;55(1):90-4. doi: 10.1093/jac/dkh488. Epub 2004 Dec 1.
4
Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections.
Diagn Microbiol Infect Dis. 2009 Feb;63(2):208-12. doi: 10.1016/j.diagmicrobio.2008.10.004. Epub 2008 Nov 21.
5
Insufficient penetration of systemic vancomycin into the PermCath lumen.
Nephrol Dial Transplant. 2000 Jul;15(7):1035-7. doi: 10.1093/ndt/15.7.1035.
6
Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy.
J Antimicrob Chemother. 2006 Oct;58(4):816-21. doi: 10.1093/jac/dkl318. Epub 2006 Aug 8.
8
Barriers to antibiotic lock therapy in children with intravascular catheter-related bloodstream infections.
Pediatr Infect Dis J. 2005 Oct;24(10):944. doi: 10.1097/01.inf.0000181547.71123.c8.
9
Antibiotic-heparin lock: in vitro antibiotic stability combined with heparin in a central venous catheter.
Pharmacotherapy. 2000 Apr;20(4):394-9. doi: 10.1592/phco.20.5.394.35063.

引用本文的文献

1
Antibiotic lock therapy: review of technique and logistical challenges.
Infect Drug Resist. 2014 Dec 12;7:343-63. doi: 10.2147/IDR.S51388. eCollection 2014.
3
Antibiotic and other lock treatments for tunnelled central venous catheter-related infections in children with cancer.
Cochrane Database Syst Rev. 2013 Jun 25;2013(6):CD008975. doi: 10.1002/14651858.CD008975.pub2.
4
Prophylaxis of catheter-related bacteremia using tissue plasminogen activator-tobramycin locks.
Pediatr Nephrol. 2009 Nov;24(11):2233-43. doi: 10.1007/s00467-009-1235-5. Epub 2009 Jul 10.
5
Comparison of early versus late use of antibiotic locks in the treatment of catheter-related bacteremia.
Clin J Am Soc Nephrol. 2008 Jul;3(4):1048-56. doi: 10.2215/CJN.04931107. Epub 2008 Apr 9.
6
Treatment of catheter-related bacteremia with tissue plasminogen activator antibiotic locks.
Pediatr Nephrol. 2008 Mar;23(3):457-64. doi: 10.1007/s00467-007-0687-8. Epub 2007 Dec 6.
7
Decreasing gradient of antibiotic concentration in the lumen of catheters locked with vancomycin.
Eur J Clin Microbiol Infect Dis. 2007 Sep;26(9):659-61. doi: 10.1007/s10096-007-0356-7.

本文引用的文献

1
3
Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports).
Antimicrob Agents Chemother. 1999 Aug;43(8):2074-6. doi: 10.1128/AAC.43.8.2074.
4
Catheter-sepsis during home parenteral nutrition: use of the antibiotic-lock technique.
Nutrition. 1998 May;14(5):466-8. doi: 10.1016/s0899-9007(98)00020-3.
5
Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.
Clin Infect Dis. 1998 Jan;26(1):1-10; quiz 11-2. doi: 10.1086/516284.
7
Bloodstream infection from a Port-A-Cath: successful treatment with the antibiotic lock technique.
Infect Control Hosp Epidemiol. 1996 Dec;17(12):772. doi: 10.1086/647231.
9
Treatment of Hickman catheter sepsis using antibiotic lock technique.
Infect Control Hosp Epidemiol. 1995 Oct;16(10):596-8. doi: 10.1086/647015.
10
Infectious morbidity associated with long-term use of venous access devices in patients with cancer.
Ann Intern Med. 1993 Dec 15;119(12):1168-74. doi: 10.7326/0003-4819-119-12-199312150-00003.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验